Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Perindopril Erbumin, Amlodipine Besilate, Atc Code: C09bb04 for the Period from 07/01/2023 to 06/30/2025

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Completion of a Non-Excl. Discount Agreement According to § 130C Paragraph 1 Sgb V for Tofacitinib, Atc Code: L04aa29 for the Period from July 1St, 2023 to June 30Th, 2025

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Open House Original Rebate Contracts 2023-17 - Empagliflozin

Open House Wmo Tools Nissewaard

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Epinephrine, Atc C01ca24 for the Period 07/01/2023 - 06/30/2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Fluticasone Vilanterol Umeclidinium, Atc R03al08 for the Period 07/01/2023 - 06/30/2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for the Active Substance Lenalidomide (Only N3 Sizes), Atc L04ax04 for the Period July 1St, 2023 - June 30Th, 2025